2016 annual financial data

Corcept Therapeutics 2016 Financial results

Corcept Therapeutics 2016 financial results with verified reported values.

Direct answer

Revenue was 81,321,000 USD.

Operating income was 10,179,000 USD and net income was 8,140,000 USD.
Operating cash flow was 18,391,000 USD.

Get free Corcept Therapeutics email updates.

Bullstory sends one daily email when new analysis or important company news is available.

Verified data

Revenue
81,321,000 USD
Operating income
10,179,000 USD
Net income
8,140,000 USD
Operating cash flow
18,391,000 USD